Atopic Dermatitis
Feature
Do You Have Patients With JAKne — JAK Inhibitor–Associated Acne? Here’s What to Know
Janus kinase (JAK) inhibitor-associated acne may be overlooked outside of dermatology, experts said.
Latest News
Second Treatment for Prurigo Nodularis Approved by FDA
Nemolizumab is currently under FDA review for treating atopic dermatitis in...
Latest News
Storybooks Can Help Children Deal with Skin Conditions
“There are tools to help kids cope with their skin conditions, but we’re underutilizing them,” Dr. Sonia Havele said.
Latest News
Nemolizumab Benefits Seen in Adults, Teens With Atopic Dermatitis
Significant improvements in pruritus were observed as early as week 1, with a greater proportion of participants in the nemolizumab vs placebo...
Latest News
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...
Latest News
Management, Evaluation of Chronic Itch in Older Adults
A malignancy workup should be strongly considered in patients whose itch duration is less than 12 months -- and especially if the duration is less...
Latest News
Several Skin Conditions More Likely in Children With Obesity
Investigators collected data on several skin conditions and comorbidities in a retrospective cohort study.
Latest News
Dermatoporosis in Older Adults: A Condition That Requires Holistic, Creative Management
Dermatoporosis was described in the literature in 2007 by dermatologists at the University of Geneva in Switzerland.
Latest News
Managing Atopic Dermatitis in Older Adults: A Common, Unique Challenge
In one study, adults aged > 60 years showed more lesions on the trunk and extensor sites of the extremities and lower levels of serum IgE and...
Latest News
Studies Show Dupilumab Effects In Children with Both Atopic Dermatitis and Alopecia
Overall, 77.4% of patients in the trials achieved hair regrowth with dupilumab treatment.
Latest News
Topical PDE4 Inhibitor Now Approved for Atopic Dermatitis in Children, Adults
Among children and adults who participated in the INTEGUMENT studies for 28 and 56 weeks, 61.3% and 65.7% saw a 75% reduction in their Eczema Area...